8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed Jun 2, 2022 · 4y ago · Accession 0001564590-22-022228
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Xenon Pharmaceuticals Inc.
- Ticker
- XENE
- CIK
- 1582313
- Form type
- 8-K
- Filing date
- Jun 2, 2022
- Report date
- Jun 1, 2022
- Document
- xene-8k_20220601.htm
- Size
- 729 KB